EMA Recommends a Change to the Terms of the Marketing Authorisation for Mosunetuzumab By Ogkologos - October 23, 2025 239 0 Facebook Twitter Google+ Pinterest WhatsApp It adopted a new route for administration along with a new pharmaceutical form Source RELATED ARTICLESMORE FROM AUTHOR Weight Loss Treatments Linked to Lower Risk of Obesity-Related Cancers in People Without Diabetes EMA Recommends Granting a Marketing Authorisation for Camizestrant ESMO Calls for the Ring-Fenced Funding of Health Under the 2028-2034 Long-Term Budget of the EU, the Multiannual Financial Framework (MFF) MOST POPULAR FX-909 Demonstrates Acceptable Safety and Preliminary Antitumour Activity, Establishing a Proof... March 23, 2026 US lung cancer data points to the power of cancer research August 18, 2020 2023 ASCO Annual Meeting Research Round Up: Progress in Preventing Melanoma... September 12, 2023 Decorated Veteran Learns She Has Triple-Positive Breast Cancer While Pregnant with... July 9, 2021 Load more HOT NEWS Steps towards a smokefree society Telehealth Can Save People with Cancer Time, Travel, and Money Study Finds That Gut Bacteria Could Be Used to Minimize Digestive... TILs Therapy Shows Promise in the Management of Anti-PD-1-Resistant Metastatic NSCLC
